Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
187
-
Total 13F shares, excl. options
-
53.5M
-
Shares change
-
-1.76M
-
Total reported value, excl. options
-
$839M
-
Value change
-
-$31.8M
-
Put/Call ratio
-
0.3
-
Number of buys
-
90
-
Number of sells
-
-81
-
Price
-
$15.69
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q4 2021
218 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.5M shares
of 58.9M outstanding shares and own 90.84% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.83M shares), VANGUARD GROUP INC (3.88M shares), STATE STREET CORP (3.33M shares), RENAISSANCE TECHNOLOGIES LLC (3.21M shares), MACQUARIE GROUP LTD (2.91M shares), Palo Alto Investors LP (2.83M shares), LSV ASSET MANAGEMENT (2.26M shares), DIMENSIONAL FUND ADVISORS LP (2.03M shares), Epoch Investment Partners, Inc. (1.96M shares), and GOLDMAN SACHS GROUP INC (1.7M shares).
This table shows the top 187 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.